Mechanism
This integral membrane protein stimulates adenylate cyclase activity in the presence of adenosine. This protein also interacts with netrin-1, which is involved in axon elongation.Gene
The gene is located near the Smith-Magenis syndrome region on chromosome 17.Ligands
Research into selective A2B ligands has lagged somewhat behind the development of ligands for the other three adenosine receptor subtypes, but a number of A2B-selective compounds have now been developed, and research into their potential therapeutic applications is ongoing.Agonists
* BAY 60-6583 * NECA (N-ethylcarboxamidoadenosine) * (S)-PHPNECA - high affinity and efficacy at A2B, but poor selectivity over other adenosine receptor subtypes * LUF-5835 * LUF-5845 - partial agonistAntagonists and inverse agonists
* Compound 38: antagonist, high affinity and good subtype selectivity * ISAM-R56A: non-xanthinic high affinity selective antagonist (K''i'': 1.50 nM) * ISAM-140: non-xanthinic selective antagonist (K''i'' = 3.49 nM). * ISAM-R324A: Soluble and metabolically stable non-xanthinic selective antagonist (K''i'' = 6.10 nM). * ATL-801 * CVT-6883 * MRS-1706 * MRS-1754 * OSIP-339,391 * PSB-603: xanthinic antagonist * PSB-0788: xanthinic antagonist * PSB-1115: xanthinic antagonist * PSB-1901: xanthinic antagonist with picomolar potencyReferences
Further reading
* * * * * * * * * * * * * * * * * *External links
* * {{Adenosinergics Adenosine receptors